Skip to content

Precision research on dual filtration plasmapheresis (DFPP) treatment for patients with antibody-mediated rejection (ABMR) after kidney transplantation

Precision research on dual filtration plasmapheresis (DFPP) treatment for patients with antibody-mediated rejection (ABMR) after kidney transplantation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600126855
Enrollment
Unknown
Registered
2026-06-17
Start date
2025-05-24
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Antibody-mediated rejection occurs after kidney transplantation

Interventions

Observation group:None

Sponsors

The First Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who underwent kidney transplantation and were diagnosed with ABMR (DSA positive + Banff classification diagnosis of ABMR or mixed type rejection) and received DFPP treatment;

Exclusion criteria

Exclusion criteria: Combined severe infection, coagulopathy, and biopsy contraindications.

Design outcomes

Primary

MeasureTime frame
DSA antibody?serum creatinine;

Secondary

MeasureTime frame
Blood coagulation routine test, humoral immunity;Pathology of the transplanted kidney;Urinary proteinor urinary albumin/creatine;

Countries

China

Contacts

Public ContactYin Ying

The First Affiliated Hospital of Soochow University

yinyingcici@163.com+86 512 67973374

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 29, 2026